Evaluation of Drug Spread in Ultrasound-Guided Erector Spina Plane Block With Fluoroscopy

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Pain, MyofacialBack Pain
Interventions
PROCEDURE

Erector spinae plane block

"Patients will be placed in prone position. Mild sedation will be achieved by using 1-2 mg of midazolam and 50-75 µg of fentanyl iv. The application area will be visualized with General Electrics (GE) Logiq e Ultrasound device using 10-12 MHz linear probe or convex probe. Transverse process and erector spinae muscles will be visualised at the target vertebral level. Following local anesthesia (1-2 cc 2% lidocaine) application to the insertion site, a 20 gauge spinal needle will be inserted using the in-plane technique. The needle will be advanced up to the transverse process under ultrasound guidance. After confirming needle position with hydrodissection, 40 mg triamcinolone, 10 cc 0,5% bupivacaine, 10 cc radiopaque contrast agent solution will be injected. Imaging will performed in AP and lateral positions with fluoroscopy immediately and 30 minutes after the injection to evaluate intectate spread."

Trial Locations (1)

34093

Halil Cetingok, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER

NCT05114200 - Evaluation of Drug Spread in Ultrasound-Guided Erector Spina Plane Block With Fluoroscopy | Biotech Hunter | Biotech Hunter